1 / 12

Aerosol Delivery Devices Market to Reach US$ 20,918.7 million by 2027

The global aerosol delivery devices market size is projected to grow from USD 14,392.4 million in 2020 to USD 20,918.7 million by 2027, registering a CAGR of 4.9% during the forecast period from 2021 to 2027.

vipin13
Télécharger la présentation

Aerosol Delivery Devices Market to Reach US$ 20,918.7 million by 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Market Research Report EXCLUSIVE EDITION Global Aerosol Delivery Devices Market Report Opportunities, and Forecast By 2030 Global Industry Analysis, Forecast and Trends, 2022-2030 © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807

  2. Aerosol Delivery Devices Market © 2020 Statsville Consulting Private Limited Market Statsville Group (MSG) A part of Statsville Consulting Private Limited American Office American Office – 800 Third Avenue Suite A #1519 New York, NY 10022 EMEA EMEA– 1165 Budapest 16 Diósy Lajos u. 24., Europe Asia Asia- -Pacific Office Pacific Office – F-178 Subhash Marg C Scheme, Ashok Nagar, Jaipur, Rajasthan, 302001 www.marketstatsville.com Disclaimer Disclaimer: : Any information and/or material provided by Statsville Consulting Private Limited, including any and all the analysis and/or research from Market Statsville Group (MSG), is offered to a selected group of customers in response to orders for such information, material, analysis, and/or research. As a customer of Statsville Consulting, you acknowledge that our information, material, and/or services are for your internal use only, and not for any external use and/or dissemination, or general publication, and/or disclosure to any third parties. Any and all the information and/or material provided by Statsville Consulting are based on primary interviews and/or secondary research, and are, therefore, subject to fluctuation and variance. Statsville Consulting takes no responsibility for any incorrect information and/or material supplied to us by sources we rely on, and no part of our analysis or research may be given, lent, resold, or disclosed to any third parties, including non-customers, without explicit or written permission from Statsville Consulting. Unauthorized reproduction and/or transmission of our information, material, analysis, and/or research in any form and by any means, including photocopying, mechanical/electronic recording,or otherwise, without the explicit and written permission of Statsville Consulting, is expressly and clearly prohibited. Any use of the information, material, analysis, and/or research provided by Statsville Consulting is at your sole risk; you acknowledge that the information, material, analysis, and/or research is provided “as is” and that Statsville Consulting provides no warranty of any kind, express or implied, with regard to the information, material, analysis, and/or research, including but not limited to, merchantability and fitness for any purpose and/or use. At the end, Statsville Consulting will be responsiblefor the final decision of any action. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807

  3. ABOUT MARKET STATSVILLE GROUP (MSG) Market Statsville Group (MSG) partners with companies and society to confront their essential risks and challenges to capture the enormous opportunities for them. MSG was initiated its working in 2017, and since then, the brand is moving to become a pioneer in business advisory and market research services. Market Statsville is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in the form of market sizing, analysis, and incisive business insights. MSG experienced research analysts are proficient at digging deep and providing a variety of customizable data that help you make decisions with clarity, confidence, and impact. Market Statsville is your global data intelligence partner for reliable market research data, data gathering, and analytical services. MSG also has an extensive network of top-flight domestic and global research personals around the world, enabling us to provide high-quality worldwide research solutions that cater to a well-established company, government organizations, or a startup. MSG's clients have the authority to work directly with one or more of our researchers to gather the most useful data knowledge and analytical plan to formulate it in the actual practice. Market Statsville Group believes that to succeed, companies or individuals must blend digital and human capabilities most efficiently. MSG diverse and experienced global team of business consultants and market researchers will ensure the valuable reports for our clients through digging in-depth market information and functional expertise to continuously spark the changes and real-time valuation of variation in the market/industry. MSG works in a uniquely collaborative model throughout the business process across the globe to assist the client's company with the most accurate information that they are aiming for in the reports. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807

  4. RESEARCH PROCESS Our research is an optimum culmination of secondary and primary research, with the latter playing a major role. We also have an in-house repository and access to a number of external regional and global paid databases to help address specific requirements of our clients. The research process begins with a holistic secondary research, followed by expert interviews. The information gathered is then comprehensively analyzed by our highly experienced in-house research panel © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807

  5. Aerosol Delivery Devices Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Development Scenario, Opportunities, and Forecast By 2027 Aerosol Delivery Devices Market by Component (Solution, Service), by Waste Type (Solid Waste, Special Waste, E-Waste), by Smart Method (Collection, Processing, Disposal, Energy Recovery), by Application, by Region – Global Share and Forecast to 2027 Description The global aerosol delivery devices market size is projected to grow from USD 14,392.4 million in 2020 to USD 20,918.7 million by 2027, registering a CAGR of 4.9% during the forecast period from 2021 to 2027. Aerosol delivery devices are hand-held, portable drug distribution devices. They consist of a suspension of liquid or solid particles in a carrier gas, making it feasible to treat lungs and non-respiratory diseases. Different drugs are available for aerosol drug delivery, such as dry powder, solution, and suspension. It is the most advanced drug administration in which aerosolized drug is directly delivered to the lungs to offer a systemic outcome. Aerosol delivery devices are available in three categories: dry powder inhalers, nebulizers, and metered-dose inhalers. Aerosol drug delivery is a natural treatment and the easiest way to treat respiratory diseases like asthma, cystic fibrosis, and COPD. Furthermore, it is used to deliver insulin, analgesic medications, and other drugs as well. Increase in prevalence of COPD, asthma, and other respiratory disorders, increase in smoking population, ease of administration of the drug with aerosol delivery devices, rise in demand for metered-dose inhalers, technological developments in inhaler devices, and rise in aged population are the key factors that fuel the growth of the global aerosol delivery devices market. For instance, according to the WHO (World Health Organization), in 2018, more than 339 million people were affected by asthma worldwide. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807

  6. Request Sample Copy of this Report: https://www.marketstatsville.com/request-sample/aerosol- delivery-devices-market Furthermore, rise in the adoption of aerosol delivery devices by patients, increase in patient awareness toward inhalation therapy, the surge in preference of pulmonary route of drug delivery, rise in pollution levels and urbanization, increase in incidences of preterm births and lifestyle changes, and growth in the number of R&D activities to grow ideal inhalation therapy are other factors that contribute toward the development of the market. However, complications and side-effects associated with drug inhalation and the high cost associated with nebulizers are expected to hinder the market's growth. COVID-19 Impact on the Global Aerosol Delivery Devices Coronavirus was discovered in late December in Hubei province of Wuhan city in China. The illness is caused by a virus, namely, severe acute respiratory syndrome coronavirus, which is spread from human to human. After its discovery in Wuhan, the disease speedily increased in other parts of the globe. Moreover, this virus causes various symptoms in a patient, ranging from common symptoms to serious symptoms. On 11th March 2020, the WHO (World Health Organization) assessed that COVID-19 could be characterized as a pandemic. In moreover, there are no drugs that are currently licensed for COVID-19 treatment or prevention. Thus, social distancing is observed as the most important measure to stop the spread of this disease. Furthermore, to maintain social distancing, various countries across the world have adopted nationwide lockdowns. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807 6

  7. Global Aerosol Delivery Devices Market Dynamics Drivers: Increase in air pollution The rise in air pollution due to smoke that comes out of the vehicle and pollution caused by anthropogenic sources is the primary factor attributed to the increase in the prevalence of COPD and asthma. Various research studies showed that asthma symptoms deteriorate by air pollution. For instance, a study conducted on young campers suffering from moderate to severe asthma displayed results that they were 40% more prone to suffer from acute asthma incidents on days when pollution level was as compared to average pollution days. Two key air pollutants severely trigger asthma: ozone, which is found in smog, and particulate matter found in smoke, haze, and dust. Susceptibility of suffering from asthma symptoms is on the rise at an alarming rate, as the presence of both ozone and particulate matter is on the increase in the air. Thus, a surge in air pollution is expected to directly lead to the rise in cases of asthma and COPD, which, in turn, propel the market's growth. Restraints: High cost of asthma and COPD treatments COPD and asthma treatments are time-consuming and expensive, among which cost is a significant concern that there is no one-time solution for the problem. The sudden asthma attack requires rescue inhalers, which are not widely used in low-income countries, owing to their higher costs. Globally, the most asthmatic population is from low-income countries; therefore, the high cost of the treatment creates a problem for them. According to the American Thoracic Society 2019, health care costs for asthma in the U.S. are estimated to total around USD 300 billion over the next 20 years. In addition, the yearly cost of asthma in the U.S. is around USD 56 billion. Therefore, every year increase in price for the treatment of asthma is expected to hamper the market's growth. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807 7

  8. Opportunities: Growth opportunities in emerging markets The rise of the aerosol delivery devices market is expected to be driven by opportunities in untapped, emerging markets, owing to the increase in the adoption of unhealthy lifestyles, the surge in urbanization, exposure to smoke & chemicals, and a subsequent rise in the prevalence chronic obstructive pulmonary disease. For instance, according to the CDC (Centers for Disease Control and Prevention), in the U.S., the overall prevalence of COPD was 6.2% in 2017. Moreover, according to the WHO, COPD is expected to be the third leading cause of death worldwide by 2030. The healthcare industry in developed countries is developing significantly, owing to increased demand for better-advanced manufacturing systems and significant investments by governments to improve healthcare infrastructure. Furthermore, emerging markets such as India and China are hubs for pharmaceutical and medical device companies, which provide lucrative opportunities for the market's growth. Scope of the Report The study categorizes the aerosol delivery devices market based on product, distribution channel, application, and regions. Direct Purchase Report: https://www.marketstatsville.com/buy-now/aerosol-delivery-devices-market?opt=2950 By Product Outlook (Revenue, USD Million, 2017-2027) •Dry powder inhalers • Single-dose inhalers • Multi-dose inhalers •Metered-dose inhalers • Conventional pressurized inhalers, • Soft mist inhalers •Nebulizers • Jet nebulizers • Ultrasonic wave nebulizers • Vibrating mesh nebulizers © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807 8

  9. By Distribution Channel Outlook (Revenue, USD Million, 2017-2027) •Retail pharmacies •Hospital pharmacies •E-commerce By Application Outlook (Revenue, USD Million, 2017-2027) •Asthma •Chronic obstructive pulmonary disease •Cystic fibrosis •Non-respiratory diseases • Diabetes • Analgesia • Parkinson’s disease By Region Outlook (Sales, USD Million, 2017-2027) •North America (US, Canada, Mexico) •South America (Brazil, Argentina, Colombia, Peru, Rest of Latin America) •Europe (Germany, Italy, France, UK, Spain, Poland, Russia, Slovenia, Slovakia, Hungary, Czech Republic, Belgium, the Netherlands, Norway, Sweden, Denmark, Rest of Europe) •Asia Pacific (China, Japan, India, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Cambodia, the Philippines, Singapore, Australia & New Zealand, Rest of Asia Pacific) •The Middle East & Africa (Saudi Arabia, UAE, South Africa, Northern Africa, Rest of MEA) © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807 9

  10. By product type, the metered-dose inhaler segment is projected to account for the largest market share The aerosol delivery devices market is categorized into dry powder inhalers, metered-dose inhalers, and nebulizers based on product. The metered-dose inhaler segment is expected to account for the largest revenue in 2020. It is projected to grow at a CAGR of 4.4% during the forecast period, owing to rise in incidences of asthma, cystic fibrosis, and COPD, the surge in patient awareness toward effective & advanced respiratory devices, and the launch of effective products, which are tested under the clinical trials by various companies to confirm better therapeutic outcomes. Access full Report Description, TOC, Table of Figure, Chart, etc: https://www.marketstatsville.com/table-of-content/aerosol-delivery-devices- market MDIs deliver medicine to patients in the form of mist. They are used to treat numerous respiratory diseases such as asthma, COPD, and cystic fibrosis. They were developed in 1950 by Thiel Riker laboratories, which provides bronchodilator drugs formulations in pressurized containers with greater convenience and reliable doses of medication. This bronchodilator drug formulation development led to the introduction of proprietary pressurized metered-dose inhalers (pMDIs). Metered-dose inhalers provide advantages such as multiple-dose convenience, short treatment time, reproducible emitted doses, no requirement for drug preparation, and are less prone to contamination. However, there are several disadvantages of metered-dose inhalers, including the need for hand-breath coordination and reaction to propellants in some patients. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807 10

  11. Asia Pacific accounts for the highest CAGR during the forecast period Based on the region, the global aerosol delivery devices market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. Asia-Pacific is analyzed across Japan, China, India, Australia, South Korea, and the Rest of Asia-Pacific. This region is growing at a CAGR 6.4% share in the global aerosol delivery devices market. The market development in this region is attributable to a rise in the geriatric population and a growth in the number of smokers. For instance, according to Japan's Internal Affairs and Communications Ministry, Japan had around 35.57 million geriatric population in 2018. Request For Report Description: https://www.marketstatsville.com/aerosol- delivery-devices-market © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1 (646) 663-5829 | +91-702-496-8807 11

  12. Thank You Thank You Market Market Statsville StatsvilleGroup (MSG) Group (MSG) F-178 Subhash Marg C Scheme, Ashok Nagar, Jaipur, Rajasthan, 302001 Phone : +91 702 496 8807 Mail : sales@marketstatsville.com 800 Third Avenue Suite A #1519 New York, NY 10022 Phone : +1 (646) 663-5829 Mail : sales@marketstatsville.com

More Related